ArticleJournal of hematology & oncology2022
A novel tRNA-derived fragment AS-tDR-007333 promotes the malignancy of NSCLC via the HSPB1/MED29 and ELK4/MED29 axes.
Wenhan Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
85 papers cite itlatest 60 shown
this paperpooled itcites it